Brooks Laboratories Limited focuses on critical care products including Beta Lactam, Cephalosporin, and General Dry powder Injectables. It provides a diverse product portfolio for multiple companies.

Brooks Laboratories major competitors are Medico Remedies, Lyka Labs, Fredun Pharma, Trident Lifeline, Albert David, Gennex Lab, Zim Laboratories.
Market Cap of Brooks Laboratories is ₹393 Crs.
While the median market cap of its peers are ₹409 Crs.

Brooks Laboratories seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.